These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9669469)

  • 81. Efficacy and safety of i.v. methylprednisolone pulse therapy for vitiligo: A retrospective study of 58 therapy experiences for 33 vitiligo patients.
    Wada-Irimada M; Tsuchiyama K; Sasaki R; Hatchome N; Watabe A; Kimura Y; Yamasaki K; Aiba S
    J Dermatol; 2021 Jul; 48(7):1090-1093. PubMed ID: 33768620
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Effect of glucocorticoid combined with gamma globulin in treatment of children with myasthenia gravis and its effects on immune globulin and complement of children.
    Wang MG; Huang XX; Yao D; An Q; Deng XQ
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2404-8. PubMed ID: 27338067
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Breathing pattern and central ventilatory drive in mild and moderate generalised myasthenia gravis.
    García Río F; Prados C; Díez Tejedor E; Díaz Lobato S; Alvarez-Sala R; Villamor J; Pino JM
    Thorax; 1994 Jul; 49(7):703-6. PubMed ID: 8066568
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [A rare case of severe generalized myasthenia against a background of pregnancy].
    Romanchishen AF; Chukhlovina ML; Kolosiuk VA
    Vestn Khir Im I I Grek; 2000; 159(1):100-1. PubMed ID: 10890114
    [No Abstract]   [Full Text] [Related]  

  • 85. Clinical impact of intravenous methylprednisolone in attacks of multiple sclerosis.
    Nos C; Sastre-Garriga J; Borràs C; Río J; Tintoré M; Montalban X
    Mult Scler; 2004 Aug; 10(4):413-6. PubMed ID: 15327039
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Is cerebral involvement an occasional feature of muscle-specific kinase antibody-positive syndrome?
    Bhagavati S; Maccabee PJ; Chari G
    Eur J Neurol; 2007 Aug; 14(8):e21-2. PubMed ID: 17661994
    [No Abstract]   [Full Text] [Related]  

  • 87. Myasthenia gravis: an unusual cause of diplopia in polymyalgia rheumatica.
    Fernández-Castro M; Andreu JL; Muñoz P; Ornilla E
    Clin Exp Rheumatol; 2004; 22(4):505. PubMed ID: 15301257
    [No Abstract]   [Full Text] [Related]  

  • 88. Pharmacology of myasthenia gravis.
    Dipalma JR
    Am Fam Physician; 1980 Oct; 22(4):158-9. PubMed ID: 7424763
    [No Abstract]   [Full Text] [Related]  

  • 89. Mycophenolate mofetil for myasthenia gravis: a double-blind, placebo-controlled pilot study.
    Meriggioli MN; Rowin J; Richman JG; Leurgans S
    Ann N Y Acad Sci; 2003 Sep; 998():494-9. PubMed ID: 14592919
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Effect of Gender, Disease Duration and Treatment on Muscle Strength in Myasthenia Gravis.
    Citirak G; Cejvanovic S; Andersen H; Vissing J
    PLoS One; 2016; 11(10):e0164092. PubMed ID: 27741232
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Pharmacokinetic study of oral prednisolone compared with intravenous methylprednisolone in patients with juvenile dermatomyositis.
    Rouster-Stevens KA; Gursahaney A; Ngai KL; Daru JA; Pachman LM
    Arthritis Rheum; 2008 Feb; 59(2):222-6. PubMed ID: 18240180
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis.
    Uzawa A; Suzuki S; Kuwabara S; Akamine H; Onishi Y; Yasuda M; Ozawa Y; Kawaguchi N; Kubota T; Takahashi MP; Suzuki Y; Watanabe G; Kimura T; Sugimoto T; Samukawa M; Minami N; Masuda M; Konno S; Nagane Y; Utsugisawa K
    J Neurol Neurosurg Psychiatry; 2023 Jun; 94(6):467-473. PubMed ID: 36693723
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Clinical characteristics and relationship between myasthenia gravis and premature ovarian failure: report of two cases.
    Cao L; Liu W; Zhu Z
    J Int Med Res; 2019 Aug; 47(8):3992-3997. PubMed ID: 31342860
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Effectiveness of intravenous methylprednisolone pulse in patients with severe microscopic polyangiitis and granulomatosis with polyangiitis.
    Omura S; Kida T; Noma H; Inoue H; Sofue H; Sakashita A; Kadoya M; Nakagomi D; Abe Y; Takizawa N; Nomura A; Kukida Y; Kondo N; Yamano Y; Yanagida T; Endo K; Hirata S; Matsui K; Takeuchi T; Ichinose K; Kato M; Yanai R; Matsuo Y; Shimojima Y; Nishioka R; Okazaki R; Takata T; Ito T; Moriyama M; Takatani A; Miyawaki Y; Ito-Ihara T; Yajima N; Kawaguchi T; Hirano A; Fujioka K; Fujii W; Seno T; Wada M; Kohno M; Kawahito Y
    Rheumatology (Oxford); 2024 Sep; 63(9):2484-2493. PubMed ID: 38608193
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Intravenous pulse methylprednisolone and corticosteroid-induced psychiatric disorders: A retrospective study.
    Ogyu K; Mashima Y; Nishi A; Kusudo K; Kato H; Kurose S; Uchida H; Fujisawa D; Mimura M; Takeuchi H
    J Psychosom Res; 2023 Apr; 167():111179. PubMed ID: 36801660
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Influence of Methylprednisolone Pulse Therapy on Liver Function in Patients with Graves' Orbitopathy.
    Miśkiewicz P; Jankowska A; Brodzińska K; Milczarek-Banach J; Ambroziak U
    Int J Endocrinol; 2018; 2018():1978590. PubMed ID: 30420883
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Liver Dysfunction Associated with Intravenous Methylprednisolone Pulse Therapy in Patients with Graves' Orbitopathy.
    Eguchi H; Tani J; Hirao S; Tsuruta M; Tokubuchi I; Yamada K; Kasaoka M; Teshima Y; Kakuma T; Hiromatsu Y
    Int J Endocrinol; 2015; 2015():835979. PubMed ID: 26221141
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Efficacy and Safety of Pulse Intravenous Methylprednisolone in Pediatric Epileptic Encephalopathies: Timing and Networks Consideration.
    Russo A; Mazzone S; Landolina L; Colucci R; Baccari F; Fetta A; Boni A; Cordelli DM
    J Clin Med; 2024 Apr; 13(9):. PubMed ID: 38731025
    [No Abstract]   [Full Text] [Related]  

  • 99. Resolution of primary ovarian insufficiency after corticosteroid administration in a myasthenia gravis patient: Report and minireview of the literature.
    Liu X; Li R; Jing Y
    Neurol India; 2018; 66(6):1807-1810. PubMed ID: 30504586
    [No Abstract]   [Full Text] [Related]  

  • 100. Observation on the efficacy of different methylprednisolone regimens in the treatment of myasthenia gravis.
    Lin X; Qi G
    Pak J Med Sci; 2022; 38(4Part-II):910-915. PubMed ID: 35634618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.